Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

T cells become licensed in the lung to enter the central nervous system.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset.
From "Wheelchair Circuit" to "Wheelchair Assessment Instrument for People with Multiple Sclerosis": Reliability and Validity Analysis of a Test to Assess Driving Skills in Manual Wheelchair Users With Multiple Sclerosis.
Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131).
Influence of pregnancy on neuromyelitis optica spectrum disorder.
Progressive multiple sclerosis: The treatment gap.
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Biochemical Markers of Autoimmune Diseases of the Nervous System.
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.

Pages